...
首页> 外文期刊>Acta anaesthesiologica Taiwanica : >Diagnosis and insertion of Hickman catheter for a patient with persistent left superior vena cava
【24h】

Diagnosis and insertion of Hickman catheter for a patient with persistent left superior vena cava

机译:Hickman导管对持续左上腔静脉患者的诊断和插入

获取原文

摘要

A vascular access with good function for drug delivery is the basis of chemotherapy. If there is any congenital or acquired vascular abnormality, procedurally related and late complications such as vessel rupture, malposition, and dysfunction of the catheter with ensuing thrombosis may occur, especially when it is undiagnosed or ignored. We describe a case of implantable central venous catheter (CVC) malposition and subsequent insertion of a Hickman catheter for stem cell transplantation after the diagnosis of persistent left superior vena cava (PLSVC) by radiologic image studies. The case is about a 60-year-old male who suffered from mantle cell lymphoma. He complained of discomfort when chemotherapeutic drugs were delivered through an implanted subcutaneous port system. Malposition of the CVC with aberrant path venous catheter, which led to its migration to the right internal jugular vein (RIJV) was noted on the chest X-ray. In addition, results of ultrasound imaging revealed total occlusion of the RIJV, and a subsequent three-dimensional (3D) computed tomography (CT) reconstruction image revealed a PLSVC with an atretic right SVC. Ultrasound-guided venous puncture of the left internal jugular vein and intraoperative fluoroscopy for confirming the correct guide-wire path were used for successful insertion of Hickman catheter without any complication. When unexpected occurrence of migration or malposition of the long-term CVC is detected, early removal of the catheter is vital for preventing further complications. Proper and advanced image studies including ultrasound, contrast-enhanced venography, CT, and magnetic resonance imaging may be necessary for understanding the potential vascular abnormality and guiding the following treatment.
机译:具有良好的药物输送功能的血管通路是化学疗法的基础。如果存在任何先天性或后天性血管异常,则可能会发生与程序相关的晚期并发症,例如血管破裂,位置不正确以及导管功能障碍并伴有血栓形成,尤其是在无法诊断或忽略的情况下。我们描述了一例可植入的中心静脉导管(CVC)位置不正确,随后通过放射影像学研究诊断为持续性左上腔静脉(PLSVC)后,为干细胞移植插入了Hickman导管进行干细胞移植。该病例是一名患有套细胞淋巴瘤的60岁男性。他抱怨当化学治疗药物通过植入的皮下端口系统输送时感到不适。在胸部X线片上发现CVC与路径静脉导管异常,从而导致其向右颈内静脉(RIJV)迁移。此外,超声成像的结果显示RIJV完全闭塞,随后的三维(3D)计算机断层扫描(CT)重建图像显示了带有闭锁右SVC的PLSVC。超声引导左颈内静脉穿刺并进行术中透视检查以确认正确的导丝路径,可成功插入希克曼导管而无任何并发症。当检测到长期CVC发生意外迁移或位置不当时,尽早取出导管对于防止进一步的并发症至关重要。为了理解潜在的血管异常并指导后续治疗,可能需要进行适当和高级的图像研究,包括超声,对比增强的静脉造影,CT和磁共振成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号